Eric Fung has been promoted within Ciphergen’s diagnostic division to vice president of clinical and medical affairs. In his new position, Fung will manage biomarker discovery efforts within academic collaborations and direct clinical trial studies designed to achieve commercialization, the company said.
Ciphergen has also appointed Simon Shorter as vice president of business development. In his position, Shorter will oversee corporate strategy and academic business development activities, the company said.